Quinoxalines Potential to Target Pathologies

Author(s): Maria Tristan-Manzano, Antonio Guirado, Maria Martinez-Esparza, Jesus Galvez, Pilar Garcia-Penarrubia, Antonio J. Ruiz-Alcaraz

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 26 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


The study of quinoxalines has increased immeasurably during the last two decades, due firstly to their relatively simple chemical synthesis, which has generated a vast variety of compounds with diverse structural modifications, and secondly, to the wide therapeutic potential and biological activities exhibited by this family of compounds. Quinoxalines constitute a rising biomedical class of low-molecular weight heterocyclic compounds with potential functions as antitumour, anti-inflammatory, antibacterial, antiviral, antifungal, antiparasitic and antidiabetic agents, as well as being of interest for the potential treatment of glaucoma, insomnia, cardiovascular and neurological diseases, among others. However, a deeper knowledge of the molecular targets of quinoxalines that fulfil a key role in certain pathologies is required for the development of new and more specific drugs through a rational design strategy to avoid undesirable side effects. In the present review, we summarize the most important molecular targets of the quinoxaline derivatives discovered to date, thus providing a first reference index for researchers to identify the potential targets of their quinoxalines derived collections, which could facilitate the development of new quinoxaline- based therapies.

Keywords: Biomedical activity, Intracellular signaling, Molecular targets, Receptors, Quinoxaline derivatives, Therapeutic applications.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [3075 - 3108]
Pages: 34
DOI: 10.2174/0929867322666150812144104
Price: $65

Article Metrics

PDF: 28